MassIVE MSV000096318

Partial Public

The E3 ligase HECTD4 regulates COX-2 dependent tumor progression and metastasis

Subscribe Comment Reanalyze Spectra Add Reanalysis

Description

Dataset 1 Proteomics: This quantitative proteomics experiment aimed to characterize changes in global protein expression in order to identify HECTD4 substrates. For this, HECTD4-KD (n=3) and scrambled control MDA-MB-231 (n=3) cells were cultured in vitro under anchorage-independent conditions in ultra-low adherent plates for 3 days. The cells were treated with proteasome (MG132) and lysosome inhibitors (Bafilomycin-1, BafA1) for 6 hours and collected for proteomic analysis. Multiplexed mass spectrometry-based proteomics was performed using TMTpro barcoding reagents (PMID-33900084) and the SPS-MS3 method on an Orbitrap Lumos mass spectrometer. Prior to mass spectrometry analysis, the TMT set was fractionated offline by basic pH reversed-phase chromatography (bRPLC) into 24 fractions. Samples were labeled as follows 129c -Control_R1 130n - Control_R2 130c - Control_R3 131n - HECTD4 KD_R1 131c - HECTD4 KD_R2 132n - HECTD4 KD_R3 Dataset 2 DiGly Proteomics: This quantitative proteomics experiment aimed to characterize changes in protein ubiquitination in order to identify HECTD4 substrates. For this, HECTD4-KD (n=3) and scrambled control MDA-MB-231 (n=3) cells were cultured in vitro under anchorage-independent conditions in ultra-low adherent plates for 3 days. The cells were treated with proteasome (MG132) and lysosome inhibitors (Bafilomycine-1, BAF1) for 6 hours and collected for proteomic analysis. The Di-Gly peptides were enriched by co-immunoprecipitation of K-GG-modified peptides according to the manufacturers instructions (Cell Signaling PTMScan, Cat 59322). Multiplexed mass-spectrometry-based proteomics was performed using TMTpro barcoding reagents (PMID-33900084) using a high-resolution MS2 data-dependent acquisition method on an Orbitrap Lumos mass spectrometer. Before mass spectrometry analysis, the peptides were fractionated into seven fractions using Pierce High pH Reversed-Phase Peptide Fractionation Kit (Thermo Scientific Cat 84868) according to the manufacturers instructions. The six fractions were each used once, and one was used twice for the mass spectrometry analysis. Samples were labeled as follows 129c -Control_R1 130n - Control_R2 130c - Control_R3 131n - HECTD4 KD_R1 131c - HECTD4 KD_R2 132n - HECTD4 KD_R3 [doi:10.25345/C50863H7W] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: HECTD4 ; COX2 ; E3 ligase ; SPS MS3 ; Di-Gly Mapping ; TMT18 ; DatasetType:Proteomics

Contact

Principal Investigators:
(in alphabetical order) 		Daniel Haber, Massachusetts General Hospital Cancer Center and Harvard Medical School, US
Shyamala Maheswaran, Massachusetts General Hospital Cancer Center and Harvard Medical School Boston, USA
Wilhelm Haas, Massachusetts General Hospital and Harvard Medical School, United States
Submitting User: sambhavi
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

Species

Instrument

Modifications

- Dataset Reanalyses

+ Dataset History

Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.